KASHIF NASEEM: Open Payments
NPI 1699762054 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 8 companies in 2025. Trend: 2023 $468 · 2024 $470 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 2 | $34 |
| ABBVIE INC. | 1 | $34 |
| Lilly USA, LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: ACCRUFER, VRAYLAR, MOUNJARO, Cologuard Collection Kit, Ozempic, TRELEGY ELLIPTA, Dexcom G6 Transmitter, FARXIGA.
Industry payments across GA — which companies pay providers there.
